• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

LMTK3 通过 ERK/MAPK 通路促进膀胱癌的发生。

LMTK3 promotes tumorigenesis in bladder cancer via the ERK/MAPK pathway.

机构信息

Department of Urology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.

Department of Urology, Affiliated Dalian Friendship Hospital of Dalian Medical University, China.

出版信息

FEBS Open Bio. 2020 Oct;10(10):2107-2121. doi: 10.1002/2211-5463.12964. Epub 2020 Sep 16.

DOI:10.1002/2211-5463.12964
PMID:32865871
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7530379/
Abstract

Lemur tyrosine kinase 3 (LMTK3) is a key member of the serine-threonine tyrosine kinase family. It plays an important role in breast cancer tumorigenesis and progression. However, its biological role in bladder cancer remains elusive. In this study, we demonstrated that LMTK3 was overexpressed in bladder cancer and was positively correlated with bladder cancer malignancy. High LMTK3 expression predicted poor overall survival. Knockdown of LMTK3 in bladder cancer cells triggered cell-cycle arrest at G2/M phase, suppressed cell growth, and induced cell apoptosis in bladder cancer cells. Furthermore, Transwell assays revealed that reduction of LMTK3 decreased cell migration by regulating the epithelial-to-mesenchymal transition pathway. Conversely, LKTM3 overexpression was shown to promote proliferation and migration of bladder cancer cells. We assessed phosphorylation of MEK and ERK1/2 in bladder cancer cells depleted of LMTK3 and demonstrated a reduced phosphorylation status compared with the control group. Using an MAPK signaling-specific inhibitor, U0126, we could rescue the promotion of proliferation and viability in LMTK3-overexpressing cells. In conclusion, we extend the status of LMTK3 as an oncogene in bladder cancer and provide evidence for its function via the activation of the ERK/MAPK pathway. Thus, targeting LMTK3 may hold potential as a diagnostic and prognostic biomarker and as a possible future treatment for bladder cancer.

摘要

Lemur 酪氨酸激酶 3(LMTK3)是丝氨酸-苏氨酸-酪氨酸激酶家族的关键成员。它在乳腺癌的发生和发展中发挥着重要作用。然而,其在膀胱癌中的生物学作用仍不清楚。在本研究中,我们证明了 LMTK3 在膀胱癌中过表达,并且与膀胱癌的恶性程度呈正相关。高 LMTK3 表达预示着总体生存率较差。在膀胱癌细胞中敲低 LMTK3 会触发细胞周期在 G2/M 期停滞,抑制细胞生长,并诱导膀胱癌细胞凋亡。此外,Transwell 测定显示,通过调节上皮间质转化途径,降低 LMTK3 的表达会减少细胞迁移。相反,LMTK3 的过表达被证明能促进膀胱癌细胞的增殖和迁移。我们评估了 LMTK3 耗尽的膀胱癌细胞中 MEK 和 ERK1/2 的磷酸化状态,并与对照组相比显示出磷酸化状态降低。使用 MAPK 信号通路特异性抑制剂 U0126,我们可以挽救 LMTK3 过表达细胞中增殖和活力的促进作用。总之,我们将 LMTK3 作为膀胱癌中的癌基因的状态进行了扩展,并通过激活 ERK/MAPK 通路提供了其功能的证据。因此,靶向 LMTK3 可能作为膀胱癌的诊断和预后生物标志物,并可能成为未来膀胱癌的一种治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61c5/7530379/65b2bc6d52ac/FEB4-10-2107-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61c5/7530379/053709b8e107/FEB4-10-2107-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61c5/7530379/a225eb684a06/FEB4-10-2107-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61c5/7530379/e4cea1c15f01/FEB4-10-2107-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61c5/7530379/36b4addd5889/FEB4-10-2107-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61c5/7530379/14ff9223be46/FEB4-10-2107-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61c5/7530379/bf11912841ec/FEB4-10-2107-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61c5/7530379/52d2cc170918/FEB4-10-2107-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61c5/7530379/65b2bc6d52ac/FEB4-10-2107-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61c5/7530379/053709b8e107/FEB4-10-2107-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61c5/7530379/a225eb684a06/FEB4-10-2107-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61c5/7530379/e4cea1c15f01/FEB4-10-2107-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61c5/7530379/36b4addd5889/FEB4-10-2107-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61c5/7530379/14ff9223be46/FEB4-10-2107-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61c5/7530379/bf11912841ec/FEB4-10-2107-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61c5/7530379/52d2cc170918/FEB4-10-2107-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61c5/7530379/65b2bc6d52ac/FEB4-10-2107-g008.jpg

相似文献

1
LMTK3 promotes tumorigenesis in bladder cancer via the ERK/MAPK pathway.LMTK3 通过 ERK/MAPK 通路促进膀胱癌的发生。
FEBS Open Bio. 2020 Oct;10(10):2107-2121. doi: 10.1002/2211-5463.12964. Epub 2020 Sep 16.
2
Decreased TRPM7 inhibits activities and induces apoptosis of bladder cancer cells via ERK1/2 pathway.TRPM7表达降低通过ERK1/2信号通路抑制膀胱癌细胞活性并诱导其凋亡。
Oncotarget. 2016 Nov 8;7(45):72941-72960. doi: 10.18632/oncotarget.12146.
3
Lemur tyrosine kinase-3 (LMTK3) induces chemoresistance to cetuximab in colorectal cancer via the ERK/MAPK pathway.灵长类动物酪氨酸激酶-3(LMTK3)通过 ERK/MAPK 通路诱导结直肠癌对西妥昔单抗产生耐药性。
Bioengineered. 2021 Dec;12(1):6594-6605. doi: 10.1080/21655979.2021.1974655.
4
Downregulation of LAPTM5 suppresses cell proliferation and viability inducing cell cycle arrest at G0/G1 phase of bladder cancer cells.LAPTM5的下调抑制膀胱癌细胞的细胞增殖和活力,诱导细胞周期停滞于G0/G1期。
Int J Oncol. 2017 Jan;50(1):263-271. doi: 10.3892/ijo.2016.3788. Epub 2016 Dec 5.
5
LMTK3 knockdown retards cell growth and invasion and promotes apoptosis in thyroid cancer.LMTK3基因敲低可抑制甲状腺癌细胞的生长和侵袭,并促进其凋亡。
Mol Med Rep. 2017 Apr;15(4):2015-2022. doi: 10.3892/mmr.2017.6262. Epub 2017 Feb 28.
6
The multifaceted role of lemur tyrosine kinase 3 in health and disease.灵长类动物酪氨酸激酶 3 在健康和疾病中的多效性作用。
Open Biol. 2021 Sep;11(9):210218. doi: 10.1098/rsob.210218. Epub 2021 Sep 29.
7
LMTK3 confers chemo-resistance in breast cancer.LMTK3 赋予乳腺癌的化疗耐药性。
Oncogene. 2018 Jun;37(23):3113-3130. doi: 10.1038/s41388-018-0197-0. Epub 2018 Mar 15.
8
Comprehensive analysis of differentially expressed genes associated with PLK1 in bladder cancer.膀胱癌中与 PLK1 相关的差异表达基因的综合分析。
BMC Cancer. 2017 Dec 16;17(1):861. doi: 10.1186/s12885-017-3884-2.
9
MARK4 promotes the malignant phenotype of gastric cancer through the MAPK/ERK signaling pathway.MARK4 通过 MAPK/ERK 信号通路促进胃癌的恶性表型。
Pathol Res Pract. 2024 Sep;261:155471. doi: 10.1016/j.prp.2024.155471. Epub 2024 Jul 20.
10
The lncRNA MIR2052HG regulates ERα levels and aromatase inhibitor resistance through LMTK3 by recruiting EGR1.长链非编码 RNA MIR2052HG 通过招募 EGR1 来调节 LMTK3 从而调控 ERα 水平和芳香酶抑制剂耐药性。
Breast Cancer Res. 2019 Apr 3;21(1):47. doi: 10.1186/s13058-019-1130-3.

引用本文的文献

1
Chaetoglobosin A induces apoptosis in T-24 human bladder cancer cells through oxidative stress and MAPK/PI3K-AKT-mTOR pathway.球毛壳菌素A通过氧化应激和MAPK/PI3K-AKT-mTOR途径诱导T-24人膀胱癌细胞凋亡。
PeerJ. 2025 Mar 31;13:e19085. doi: 10.7717/peerj.19085. eCollection 2025.
2
Inotodiol induces hepatocellular carcinoma apoptosis by activation of MAPK/ERK pathway.麦角甾二烯二醇通过激活丝裂原活化蛋白激酶/细胞外信号调节激酶(MAPK/ERK)通路诱导肝癌细胞凋亡。
PLoS One. 2025 Jan 29;20(1):e0318450. doi: 10.1371/journal.pone.0318450. eCollection 2025.
3
Orosomucoid 1 interacts with S100A12 and activates ERK signalling to expedite the advancement of bladder cancer.

本文引用的文献

1
The lncRNA MIR2052HG regulates ERα levels and aromatase inhibitor resistance through LMTK3 by recruiting EGR1.长链非编码 RNA MIR2052HG 通过招募 EGR1 来调节 LMTK3 从而调控 ERα 水平和芳香酶抑制剂耐药性。
Breast Cancer Res. 2019 Apr 3;21(1):47. doi: 10.1186/s13058-019-1130-3.
2
Circular RNA CEP128 promotes bladder cancer progression by regulating Mir-145-5p/Myd88 via MAPK signaling pathway.环状 RNA CEP128 通过调节 MAPK 信号通路调控 Mir-145-5p/Myd88 促进膀胱癌进展。
Int J Cancer. 2019 Oct 15;145(8):2170-2181. doi: 10.1002/ijc.32311. Epub 2019 May 30.
3
KIF15 promotes bladder cancer proliferation via the MEK-ERK signaling pathway.
类粘蛋白1与S100A12相互作用并激活ERK信号传导,以加速膀胱癌的进展。
Cell Adh Migr. 2025 Dec;19(1):1-11. doi: 10.1080/19336918.2024.2434209. Epub 2024 Dec 7.
4
The lemur tail kinase family in neuronal function and disfunction in neurodegenerative diseases.神经退行性疾病中神经元功能和紊乱的狐猴尾巴激酶家族。
Cell Mol Life Sci. 2024 Nov 9;81(1):447. doi: 10.1007/s00018-024-05480-0.
5
Lemur tail kinase 3 serves as a predictor of patient outcomes and a target for the treatment of ovarian cancer.狐猴尾部激酶3可作为患者预后的预测指标及卵巢癌治疗的靶点。
Mol Ther Oncol. 2024 Aug 26;32(3):200864. doi: 10.1016/j.omton.2024.200864. eCollection 2024 Sep 19.
6
Therapeutic advances of targeting receptor tyrosine kinases in cancer.靶向治疗癌症受体酪氨酸激酶的治疗进展。
Signal Transduct Target Ther. 2024 Aug 14;9(1):201. doi: 10.1038/s41392-024-01899-w.
7
MiR-205-3p suppresses bladder cancer progression via GLO1 mediated P38/ERK activation.miR-205-3p 通过 GLO1 介导的 P38/ERK 激活抑制膀胱癌进展。
BMC Cancer. 2023 Oct 9;23(1):956. doi: 10.1186/s12885-023-11175-9.
8
The Inhibitory Properties of a Novel, Selective LMTK3 Kinase Inhibitor.新型选择性 LMTK3 激酶抑制剂的抑制特性。
Int J Mol Sci. 2023 Jan 3;24(1):865. doi: 10.3390/ijms24010865.
9
HAPLN3 inhibits apoptosis and promotes EMT of clear cell renal cell carcinoma via ERK and Bcl-2 signal pathways.HAPLN3 通过 ERK 和 Bcl-2 信号通路抑制透明细胞肾细胞癌的细胞凋亡并促进 EMT。
J Cancer Res Clin Oncol. 2023 Jan;149(1):79-90. doi: 10.1007/s00432-022-04421-3. Epub 2022 Nov 14.
10
NCAPH promotes cell proliferation and inhibits cell apoptosis of bladder cancer cells through MEK/ERK signaling pathway.NCAPH 通过 MEK/ERK 信号通路促进膀胱癌细胞的增殖并抑制细胞凋亡。
Cell Cycle. 2022 Feb;21(4):427-438. doi: 10.1080/15384101.2021.2021050. Epub 2022 Jan 2.
驱动蛋白家族成员15通过丝裂原活化蛋白激酶激酶-细胞外信号调节激酶信号通路促进膀胱癌增殖。
Cancer Manag Res. 2019 Feb 26;11:1857-1868. doi: 10.2147/CMAR.S191681. eCollection 2019.
4
RAB14 activates MAPK signaling to promote bladder tumorigenesis.RAB14 通过激活 MAPK 信号通路促进膀胱癌发生。
Carcinogenesis. 2019 Nov 25;40(11):1341-1351. doi: 10.1093/carcin/bgz039.
5
CIRBP is a novel oncogene in human bladder cancer inducing expression of HIF-1α.CIRBP 是人类膀胱癌中的一种新型癌基因,可诱导 HIF-1α 的表达。
Cell Death Dis. 2018 Oct 12;9(10):1046. doi: 10.1038/s41419-018-1109-5.
6
LMTK3 is essential for oncogenic KIT expression in KIT-mutant GIST and melanoma.LMTK3 对于 KIT 突变型 GIST 和黑色素瘤中的致癌性 KIT 表达是必需的。
Oncogene. 2019 Feb;38(8):1200-1210. doi: 10.1038/s41388-018-0508-5. Epub 2018 Sep 21.
7
LMTK3 confers chemo-resistance in breast cancer.LMTK3 赋予乳腺癌的化疗耐药性。
Oncogene. 2018 Jun;37(23):3113-3130. doi: 10.1038/s41388-018-0197-0. Epub 2018 Mar 15.
8
Lemur Tyrosine Kinase-3 Suppresses Growth of Prostate Cancer Via the AKT and MAPK Signaling Pathways.狐猴酪氨酸激酶-3通过AKT和MAPK信号通路抑制前列腺癌生长。
Cell Physiol Biochem. 2017;42(6):2582-2592. doi: 10.1159/000480220. Epub 2017 Aug 24.
9
PRC1 contributes to tumorigenesis of lung adenocarcinoma in association with the Wnt/β-catenin signaling pathway.PRC1 与 Wnt/β-catenin 信号通路相关,有助于肺腺癌的肿瘤发生。
Mol Cancer. 2017 Jun 24;16(1):108. doi: 10.1186/s12943-017-0682-z.
10
LMTK3 knockdown retards cell growth and invasion and promotes apoptosis in thyroid cancer.LMTK3基因敲低可抑制甲状腺癌细胞的生长和侵袭,并促进其凋亡。
Mol Med Rep. 2017 Apr;15(4):2015-2022. doi: 10.3892/mmr.2017.6262. Epub 2017 Feb 28.